| 1 |
34477031 | Vascular endothelial growth factor response with propranolol therapy in patients with infantile hemangioma. | 2022 Apr |
2 |
| 2 |
35240444 | Propranolol inhibits cell viability and expression of the pro-tumorigenic proteins Akt, NF-ĸB, and VEGF in oral squamous cell carcinoma. | 2022 Apr |
1 |
| 3 |
33575332 | Propranolol Participates in the Treatment of Infantile Hemangioma by Inhibiting HUVECs Proliferation, Migration, Invasion, and Tube Formation. | 2021 |
1 |
| 4 |
33715934 | Evaluation of GLUT1, IGF-2, VEGF, FGF 1, and angiopoietin 2 in infantile hemangioma. | 2021 May |
2 |
| 5 |
33776033 | Propranolol Therapy in Infantile Hemangioma: It Is Not Just About the Beta. | 2021 Apr 1 |
1 |
| 6 |
33782804 | Propranolol suppresses gastric cancer cell growth by regulating proliferation and apoptosis. | 2021 Sep |
1 |
| 7 |
34383343 | Retraction. | 2021 Nov |
1 |
| 8 |
34430434 | Propranolol inhibits infantile hemangioma by regulating the miR-424/vascular endothelial growth factor-A (VEGFA) axis. | 2021 Jul |
5 |
| 9 |
34697590 | Propranolol Suppresses Proliferation and Migration of HUVECs through Regulation of the miR-206/VEGFA Axis. | 2021 |
2 |
| 10 |
34721024 | β-Adrenergic Receptor Inhibitor and Oncolytic Herpesvirus Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic Effects on Colorectal Cancer. | 2021 |
2 |
| 11 |
32139988 | Evaluation of Effect of Propranolol on Serum Vascular Endothelial Growth Factor and Tissue Inhibitor of Metalloproteinase-2 Levels in Infantile Hemangioma. | 2020 Mar-Apr |
2 |
| 12 |
32219146 | Influence of Cytochrome P450 2D6 Polymorphisms on the Efficacy of Oral Propranolol in Treating Infantile Hemangioma. | 2020 |
1 |
| 13 |
32311699 | Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes. | 2020 Nov |
4 |
| 14 |
32854260 | Targeting β2-Adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma from Von Hippel-Lindau Disease. | 2020 Aug 25 |
1 |
| 15 |
33372436 | Serum levels of VEGF and bFGF in infantile hemangiomas treated with propranolol. | 2020 |
2 |
| 16 |
30368887 | Propranolol suppresses HUVEC viability, migration, VEGF expression, and promotes apoptosis by downregulation of miR-4295. | 2019 Apr |
5 |
| 17 |
30448832 | Propranolol Suppresses Cobalt Chloride-Induced Hypoxic Proliferation in Human Umbilical Vein Endothelial Cells in vitro. | 2019 |
1 |
| 18 |
31176001 | Catecholamines contribute to the neovascularization of lung cancer via tumor-associated macrophages. | 2019 Oct |
1 |
| 19 |
31588689 | Beta-blockers exert potent anti-tumor effects in cutaneous and uveal melanoma. | 2019 Dec |
1 |
| 20 |
29244114 | Propranolol for gastrointestinal bleeding in two patients with continuous flow left ventricle assist device. | 2018 Jun 1 |
1 |
| 21 |
29664206 | Pigment epithelium-derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol. | 2018 Jun |
5 |
| 22 |
29790692 | Serum concentrations of VEGF and bFGF in the course of propranolol therapy of infantile hemangioma in children: Are we closer to understand the mechanism of action of propranolol on hemangiomas? | 2018 May |
3 |
| 23 |
30130526 | Propranolol inhibits proliferation and invasion of hemangioma-derived endothelial cells by suppressing the DLL4/Notch1/Akt pathway. | 2018 Oct 1 |
1 |
| 24 |
30497198 | Repurposing propranolol as an antitumor agent in von Hippel-Lindau disease. | 2018 Oct 1 |
1 |
| 25 |
28087723 | Prophylactic propranolol for prevention of ROP and visual outcome at 1 year (PreROP trial). | 2017 Sep |
1 |
| 26 |
29490757 | Promotion of Propranolol Delivery to Hemangiomas by Using Anti-VEGFR Antibody-Conjugated Poly(lactic-co-glycolic acid) Nanoparticles. | 2017 Dec 1 |
2 |
| 27 |
26991797 | Propranolol for infantile hemangioma: Effect on plasma vascular endothelial growth factor. | 2016 Nov |
2 |
| 28 |
27178307 | Serum and tissue profile of VEGF and its receptors VGFR1/R2 in children with infantile hemangiomas on systemic propranolol treatment. | 2016 Jul |
4 |
| 29 |
25523517 | Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system. | 2015 May |
5 |
| 30 |
25728347 | Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway. | 2015 Aug |
5 |
| 31 |
26238450 | The therapeutic response in Gorham's syndrome to the beta-blocking agent propranolol is correlated to VEGF-A, but not to VEGF-C or FLT1 expression. | 2015 Aug 4 |
3 |
| 32 |
26489635 | Effect of topical propranolol gel on plasma renin, angiotensin II and vascular endothelial growth factor in superficial infantile hemangiomas. | 2015 Oct |
4 |
| 33 |
26622443 | Clinical efficacy of propranolol in the treatment of hemangioma and changes in serum VEGF, bFGF and MMP-9. | 2015 Sep |
2 |
| 34 |
26665926 | [Effect of propranolol gel on plasma VEGF, bFGF and MMP-9 in proliferating infantile hemangiomas of superficial type]. | 2015 Jul |
4 |
| 35 |
24033364 | Upregulated autocrine vascular endothelial growth factor (VEGF)/VEGF receptor-2 loop prevents apoptosis in haemangioma-derived endothelial cells. | 2014 Jan |
1 |
| 36 |
24933041 | The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases. | 2014 Sep |
1 |
| 37 |
25120757 | Propranolol enhanced adipogenesis instead of induction of apoptosis of hemangiomas stem cells. | 2014 |
2 |
| 38 |
25490818 | [Expression of serum and urinary vascular endothelial growth factor-A and epidermal growth factor-like domain 7 in proliferating hemangioma treated with propranolol]. | 2014 Oct |
3 |
| 39 |
23257321 | Propranolol as an alternative treatment option for pediatric lymphatic malformation. | 2013 Jan |
1 |
| 40 |
23291092 | Propranolol given orally for proliferating infantile haemangiomas: analysis of efficacy and serological changes in vascular endothelial growth factor and endothelial nitric oxide synthase in 35 patients. | 2013 Oct |
1 |
| 41 |
23909679 | Serum-level changes of vascular endothelial growth factor in children with infantile hemangioma after oral propranolol therapy. | 2013 Sep-Oct |
4 |
| 42 |
22580939 | Propranolol induces regression of hemangioma cells through HIF-1α-mediated inhibition of VEGF-A. | 2012 Jul |
2 |
| 43 |
23092836 | Propranolol as a novel adjunctive treatment for head and neck squamous cell carcinoma. | 2012 Oct |
1 |
| 44 |
23217879 | Effects of propranolol on the proliferation and apoptosis of hemangioma-derived endothelial cells. | 2012 Dec |
2 |
| 45 |
20715173 | Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism. | 2011 May 15 |
1 |
| 46 |
22259987 | [The change of serum vascular endothelial growth factor and matrix metalloproteinases-9 in proliferative hemangioma treated with propranolol]. | 2011 Sep |
2 |
| 47 |
20732454 | Propranolol suppresses angiogenesis in vitro: inhibition of proliferation, migration, and differentiation of endothelial cells. | 2010 Nov-Dec |
3 |
| 48 |
20977754 | Effects of propranolol in combination with radiation on apoptosis and survival of gastric cancer cells in vitro. | 2010 Oct 26 |
2 |
| 49 |
21042766 | The β-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor κB signaling. | 2010 Dec |
2 |
| 50 |
19387337 | Prevention of pancreatic cancer by the beta-blocker propranolol. | 2009 Jul |
1 |